Literature DB >> 6174423

Effects of activated T cells on natural killing.

R A Knight, P Fitzharris.   

Abstract

Two populations of human blood lymphocytes--one forming rosettes with sheep erythrocytes, the other non-rosetting--are cytolytic in vitro for several long term cultured tumour-derived cell lines. A particular breast cancer-derived target cell (MDA-157) is only killed by the non-rosetting effector. Rosetting cells from normal donors infected or immunized with influenza virus augment cytolytic activity on MDA-157 targets by non-rosetting effector cells. Similar augmenting activity can be induced by incubating the rosetting population with sources of immune (gamma), but not leucocyte (alpha) interferon in vitro. This augmentation of cytolytic activity does not require compatibility at the major histocompatibility locus between the augmenting and effector populations.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6174423      PMCID: PMC1555246     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  20 in total

Review 1.  Mechanisms of activation of human natural killer cells against tumor and virus-infected cells.

Authors:  D Santoli; H Koprowski
Journal:  Immunol Rev       Date:  1979       Impact factor: 12.988

2.  Heterogeneity of human natural killer cell populations.

Authors:  M A Kall; H S Koren
Journal:  Cell Immunol       Date:  1978-09-15       Impact factor: 4.868

Review 3.  Natural cell-mediated immunity.

Authors:  R B Herberman; H T Holden
Journal:  Adv Cancer Res       Date:  1978       Impact factor: 6.242

4.  Interferon activation of "pre-spontaneous killer" (pre-SK) cells and alteration in kinetics of lysis of both "pre-SK" and active SK cells.

Authors:  S Targan; F Dorey
Journal:  J Immunol       Date:  1980-05       Impact factor: 5.422

5.  Natural cytotoxic reactivity of human lymphocyte subpopulations.

Authors:  M R Potter; M Moore
Journal:  Immunology       Date:  1979-05       Impact factor: 7.397

6.  Natural killer cells: characteristics and regulation of activity.

Authors:  R B Herberman; J Djeu; H D Kay; J R Ortaldo; C Riccardi; G D Bonnard; H T Holden; R Fagnani; A Santoni; P Puccetti
Journal:  Immunol Rev       Date:  1979       Impact factor: 12.988

7.  Modulation of natural cytotoxicity by alloantibodies. I. Alloantisera enhancement of cytotoxicity of mouse spleen cells toward a human myeloid cell line.

Authors:  R K Saxena; W H Adler
Journal:  J Immunol       Date:  1979-08       Impact factor: 5.422

8.  Spontaneous cell-mediated cytotoxicity in humans. Distribution and characterization of the effector cell.

Authors:  D Santoli; G Trinchieri; L Moretta; C M Zmijewski; H Koprowski
Journal:  Clin Exp Immunol       Date:  1978-08       Impact factor: 4.330

9.  Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis.

Authors:  G Trinchieri; D Santoli
Journal:  J Exp Med       Date:  1978-05-01       Impact factor: 14.307

10.  Relation between Epstein-Barr viral and cell membrane immunofluorescence of Burkitt tumor cells. I. Dependence of cell membrane immunofluorescence on presence of EB virus.

Authors:  G Klein; G Pearson; J S Nadkarni; J J Nadkarni; E Klein; G Henle; W Henle; P Clifford
Journal:  J Exp Med       Date:  1968-11-01       Impact factor: 14.307

View more
  3 in total

1.  Cellular cytotoxicity against autologous hepatocytes in acute and chronic non-A, non-B hepatitis.

Authors:  T Poralla; T H Hütteroth; K H Meyer zum Büschenfelde
Journal:  Gut       Date:  1984-02       Impact factor: 23.059

2.  Investigation of porcine natural-killer cell activity with reference to African swine-fever virus infection.

Authors:  S G Norley; R C Wardley
Journal:  Immunology       Date:  1983-08       Impact factor: 7.397

3.  Interferon-induced 2-5A synthetase activity in human peripheral blood mononuclear cells after immunization with influenza virus and rubella virus vaccines.

Authors:  L J Penn; B R Williams
Journal:  J Virol       Date:  1984-03       Impact factor: 5.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.